Proactive - Interviews for investors
Artrya AI Tech targets hidden heart disease risk - ASX SMIDcaps Conference
Artrya CEO John Konstantopoulos explains how the company uses AI to analyze coronary angiograms for early heart disease detection, identifying soft inflammation often missed by doctors. Their AI-driven solution aims to improve risk assessment and enable preventive care…